Clinical Trial Update: Darbepoetin Alpha in Myelodysplastic Syndromes (MDS) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update assessing darbepoetin alfa in patients with myelodysplastic syndromes; current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• darbepoetin alfa (darbepoetin alfa)

Snippet

Sponsor: Groupe Francophone des Myelodysplasies | Conditions: Myelodysplastic Syndromes | Phase 2 | Status: UNKNOWN